共 50 条
Management of osteoporosis after fragility fractures
被引:5
|作者:
Gosch, M.
[1
]
Stumpf, U.
[2
]
Kammerlander, C.
[2
,3
]
Boecker, W.
[2
]
Heppner, H. J.
[4
,5
]
Wicklein, S.
[1
]
机构:
[1] Paracelsus Med Privatuniv, Klinikum Nurnberg, Med Klin Schwerpunkt Geriatrie 2, Univ Klin Geriatrie, Campus Nurnberg,Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany
[2] Klinikum LMU, Klin Allgemeine Unfall & Wiederherstellungschirur, Munich, Germany
[3] Med Univ Innsbruck, Univ Klin Unfallchirurg, Innsbruck, Austria
[4] HELIOS Klinikum Schwelm, Klin Geriatrie, Schwelm, Germany
[5] Univ Witten Herdecke, Lehrstuhl Geriatrie, Witten, Germany
来源:
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
|
2018年
/
51卷
/
01期
关键词:
Orthogeriatrics;
Diphosphonates;
Denosumab;
Practice gap;
Therapy failure;
DOSE VITAMIN-D;
POSTMENOPAUSAL WOMEN;
D SUPPLEMENTATION;
ZOLEDRONIC ACID;
BONE EVALUATION;
HIP FRACTURE;
TASK-FORCE;
PREVENTION;
DIAGNOSIS;
REDUCTION;
D O I:
10.1007/s00391-017-1355-7
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
Osteoporosis is defined as a systemic bone disease with decreased bone strength and an increased susceptibility for fractures. Older people in particular face an increased risk of fractures. These kind of fractures are usually caused by an inadequate trauma and are the so-called fragility fractures. In older adults immediate fracture stabilization and early mobilization have become the standard procedure after a fragility fracture. Treatment of the underlying osteoporosis often plays a minor role in clinical practice. Only a small group of patients are already under osteoporosis medication and even after a fracture occurs only few patients receive osteoporosis drug treatment with the aim to reduce the progression of osteoporosis and to reduce subsequent fractures. In the literature this has been described as the osteoporosis care gap. The following article presents an overview of treatment options and answers many different questions from the clinical routine.
引用
收藏
页码:113 / 125
页数:13
相关论文